학술논문

Gait Speed Decline Is Associated with Hemoglobin A1C, Neurocognitive Impairment, and Black Race in Persons with HIV
Document Type
article
Source
AIDS Research and Human Retroviruses. 35(11-12)
Subject
Biomedical and Clinical Sciences
Immunology
HIV/AIDS
Clinical Research
Adult
Black or African American
Aging
CD4 Lymphocyte Count
Cohort Studies
Female
Glycated Hemoglobin
HIV Infections
Humans
Longitudinal Studies
Male
Middle Aged
Neurocognitive Disorders
Odds Ratio
RNA
Viral
Risk Factors
Walking Speed
gait speed
hemoglobin A1C
neurocognitive impairment
aging
Clinical Sciences
Virology
Clinical sciences
Language
Abstract
Gait speed declines at a faster rate in persons with HIV (PWH) than in the general population but the risk factors associated with this decline are not well understood. In the AIDS Clinical Trials Group (ACTG) A5322 (HAILO, HIV Infection, Aging, and Immune Function Long-term Observational Study), an observational cohort study of PWH ≥40 years of age, those who developed slow gait during the first 3 years of follow-up were compared with persons who maintained normal speed. Associations with demographic and clinical covariates were assessed using multivariable logistic regression. Of 929 participants, 81% were men, 31% Black, and 20% Hispanic. Median age was 51 years [interquartile range (IQR) = 46-56]. At study entry, 92% had plasma HIV RNA